Poster presented at the 19th ENS, Milan, Italy - Devonshire, V; Verdun, E; on behalf of the RebiSmart™ User Trial study group. Delivery Technology for Multiple Sclerosis Therapy: An international, multicentre, single-arm, open-label, 12-week, phase IIIb trial of a new electronic device for subcutaneous injection of Interferon beta-1a
June 2009.